Article Summary
王萌萌 李学荣 姜健 仲任 卢愿 宋爱琴 孙立荣.23 例儿童霍奇金淋巴瘤临床分析[J].现代生物医学进展英文版,2014,14(13):2517-2521.
23 例儿童霍奇金淋巴瘤临床分析
Clinical Analysis of 23 children with Hodgkin Lymphoma
  
DOI:
中文关键词: 霍奇金淋巴瘤  儿童  临床特征  预后  复发
英文关键词: Hodgkin lymphoma  Children  Clinical feature  Prognosis  Relapse
基金项目:国家自然科学基金项目(31100824)
Author NameAffiliation
WANG Meng-meng, LI Xue-rong, Jiang Jian, ZHONG Ren, LU Yuan, SONG Ai-qin,SUN Li-rong 青岛大学附属医院血液儿科 
Hits: 601
Download times: 377
中文摘要:
      目的:分析儿童青少年霍奇金淋巴瘤(HL)患者的病理特征、临床表现及其预后影响因素。方法:收集青岛大学医学院附属医 院血液儿科2001 年5 年至2013 年8 月收治的23 例经病理确诊的儿童青少年HL患者的临床资料,采用Fisher 确切概率法等进 行各组间差异检验。结果:确诊病例共23 例,中位年龄7.5 岁,男:女发病比例=6.7:1,Ⅰ期、Ⅱ期、Ⅲ期、Ⅳ期分别占13.0%、 26.2%、30.4%、30.4%;结节性淋巴细胞为主型(NLPHL)1 例(4.3%),经典型HL22 例(95.7%):混合细胞型(MC)10 例(43.5%),淋 巴细胞为主型(LP)11 例(47.9%),结节硬化型(NS)1 例(4.3%);受累部位以颈部淋巴结最多见,其次依次为纵隔、腹腔及腹膜后、 脾、骨骼、肺组织等,其中巨大纵隔肿块者2 例;具有B症状者8 例(34.7%)。化疗2 个疗程评估总有效率为100%,完全缓解(CR) 率69.6%,部分缓解(PR)率30.4%。Ⅰ期和Ⅱ期患者CR率100%,明显高于Ⅲ期和Ⅳ期患者(50%),P<0.05;23 例患者7 例复发, 复发率Ⅲ期和Ⅳ期患者为46.2%,Ⅰ期和Ⅱ期患者为11.1%,前者高于后者(P=0.0098);有B 症状与无B 症状患者之间复发率有 显著统计学差异(P=0.019);2 例有巨大包块患者皆复发;各病理分型与疾病的复发间差异无统计学意义(x2=2.695,P>0.05)。结 论:儿童霍奇金淋巴瘤预后相对较好,但Ⅲ期和Ⅳ期、合并B症状及大肿块或大纵隔肿瘤的患者复发率高,应依据疾病危险度分 层治疗,以期更好的预后。
英文摘要:
      Objective:To investigate the pathological characteristic, clinical features and prognosis in children and adolescent with Hodgkin's lymphoma.Methods:23 patients of childhood and adolescent with Hodgkin’s lymphoma were treated in department of pediatric Hematology of the affiliated Hospital of Qingdao university from 2001 to 2013. The clinicopathological and follow-up data of the patients were retrospectively reviewed. The clinical rate in the difference of groups was analyzed by x2 test and fisher exact test.Results:23 cases were diagnosed in the study. The mean age was 7.5 years. The sex-ratio was 6.7:1. Stage I, II, III and IV were accounted for 13.0%, 26.2%, 30.4%, 30.4%respectively. There was 1 patient of NLPHL (4.3%), 10 patients of MC (43.5%), 11 patients of LP (47.9%) and 1 patient of NS (4.3%). The involved parts were mostly the cervical lymph node, followed by mediastinum, enterocoelia, retroperitoneal, spleen, skeleton and lung tissue, of which there were 2 patients with huge mediastinummass. 8 patients had B symptoms (34.7%) at diagnosis. After 2 cycles of initial chemotherapy, the overall response rate (ORR) reached 100%. And complete response (CR) rate was 69.6%while partial response (PR) rate was 30.4%. The CR rate of patients at stage I and II (100%) was significantly higher than that at stage III and IV (50%), P<0.05. 7 of 23 patients were relapsed. The recurrence rate of stage III and IV was higher than that at stage I and II (46.2%verse 11.1%,P=0.0098). For the recurrence rate of patients, there was significantly statistical difference between patients with B symptoms and those without B symptoms (P=0.019). 2 patients with mediastinal neoplasmwere relapsed. There was no statistical difference between the relapse of disease and each histological subtype (x2=2.695, P>0.05).Conclusion:The prognosis of children and adolescent with Hodgkin's lymphoma is better, but the patients of stage III and IV or ones with B symptom and huge mediastinal lump have higher recurrence rate. The hierarchical therapy is adopted for children with HL in order to reach the long-termsurvival.
View Full Text   View/Add Comment  Download reader
Close